AI x Longevity Summit

Inaugural AI x Longevity NYC summit, bringing founders, scientists, and investors together during NYC Tech Week to explore real-world AI in

AI is rapidly reshaping how we understand and intervene on aging.

From target discovery and biomarker development to clinical decision-making and patient monitoring, AI is now embedded across the longevity stack. At the same time, much of the conversation is still disconnected from the realities of biology, data quality, and clinical translation.

The field is moving quickly, but not always clearly.

AI x Longevity NYC is designed around this moment.

As the inaugural NYC Chapter summit from Longevity Global, this event brings together a highly curated group of founders, scientists, clinicians, operators, and investors working at the intersection of AI and human healthspan.

Find this year's agenda, speaker lineup, and pitch competition information HERE.

What Will Be Covered

Day 1: Intelligence → Biology → Strategy

Day 1 is centered on how AI is being applied to biological systems and what that means for discovery and company building.

Discussions will focus on:

• How AI is being used in drug discovery, target identification, and biomarker development
• The role of data quality, experimental design, and infrastructure in enabling meaningful AI outputs
• Where models are delivering real signal versus where they are still limited
• How companies are structuring around AI, including platform strategy, data acquisition, and differentiation
• The investment landscape around AI x Bio and how capital is being deployed

The goal is to ground AI in the realities of biology and connect technical capability to real strategic decisions.

Day 2: Clinical → Systems → Scale

Day 2 shifts to how AI is being deployed in clinical and patient-facing environments and what it takes to scale.

Discussions will focus on:

• AI in longevity clinics and preventative care models
• Integration of digital health, continuous monitoring, and real-world data
• Clinical decision support and personalized intervention strategies
• Regulatory and policy considerations at the intersection of AI and healthcare
• What it takes to move from model to deployment across real patient populations

Day 2 also features:

• Live pitch competition finals for Seed and Series A companies building at the intersection of AI and longevity, with prizes and support from BioLabs at NYU Langone
• Direct interaction between founders, investors, clinicians, and pharma teams evaluating AI-driven approaches

Who This Is For

This is a space for people actively building and deploying at this intersection:

• Scientists applying AI to aging biology and disease
• Founders building AI-driven therapeutics, platforms, and diagnostics
• Investors focused on AI x Bio and digital health
• Clinicians and operators integrating AI into care models
• Pharma and BD teams evaluating new technologies
• Engineers and data scientists working on real biological and clinical systems

The format is intentionally designed to prioritize meaningful interaction over scale, creating an environment where conversations go deeper and connections are more relevant.

--

This event is a part of #NYTechWeek—a week of events hosted by VCs and startups to bring together the tech ecosystem. Learn more at www.tech-week.com.